ctrl K

Price Alert

Kestra Medical Technologi... (KMTS)

NASDAQ: KMTS · Real-Time Price · USD

25.24

0.42 (1.69%)

At close: Oct 06, 2025, 3:29 PM

Kestra Medical Common Stock Income Statement

Financials in USD. Fiscal year is May - April.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Apr 30, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2021
Revenue	59.81M	27.81M	7.63M	n/a
Cost of Revenue	35.6M	27.45M	18.28M	n/a
Gross Profit	24.21M	362K	-10.65M	n/a
Operating Income	-106.38M	-85.06M	-80.42M	-32.71M
Interest Income	3.2M	n/a	n/a	n/a
Pretax Income	-113.68M	-94.1M	-84.22M	-33.91M
Net Income	-113.81M	-94.12M	-84.24M	-34.1M
Selling & General & Admin	114.94M	69.94M	54.01M	13.9M
Research & Development	15.65M	15.49M	15.76M	18.81M
Other Expenses	n/a	n/a	n/a	n/a
Operating Expenses	130.59M	85.42M	69.77M	32.71M
Interest Expense	7.73M	6.23M	5.63M	1.17M
Selling & Marketing Expenses	n/a	40.68M	34.92M	13.9M
Cost & Expenses	166.19M	112.88M	88.05M	32.71M
Income Tax Expense	135K	24K	15K	187K
Shares Outstanding (Basic)	49.53M	49.53M	49.53M	49.53M
Shares Outstanding (Diluted)	49.53M	49.53M	49.53M	49.53M
EPS (Basic)	-5.13	-2.04	-1.75	-0.69
EPS (Diluted)	-5.13	-2.04	-1.75	-0.69
EBITDA	-97.98M	-76.31M	-73.74M	-32.33M
EBIT	-105.94M	-87.87M	-78.59M	-32.75M
Depreciation & Amortization	7.97M	11.56M	4.86M	420K